AU2002360586A1 - FLJ1115 AS MODIFIER OF THE Apaf-1 PATHWAY AND METHODS OF USE - Google Patents
FLJ1115 AS MODIFIER OF THE Apaf-1 PATHWAY AND METHODS OF USEInfo
- Publication number
- AU2002360586A1 AU2002360586A1 AU2002360586A AU2002360586A AU2002360586A1 AU 2002360586 A1 AU2002360586 A1 AU 2002360586A1 AU 2002360586 A AU2002360586 A AU 2002360586A AU 2002360586 A AU2002360586 A AU 2002360586A AU 2002360586 A1 AU2002360586 A1 AU 2002360586A1
- Authority
- AU
- Australia
- Prior art keywords
- flj1115
- apaf
- modifier
- pathway
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34031301P | 2001-12-13 | 2001-12-13 | |
US60/340,313 | 2001-12-13 | ||
US35744702P | 2002-02-15 | 2002-02-15 | |
US60/357,447 | 2002-02-15 | ||
PCT/US2002/039867 WO2003052069A2 (en) | 2001-12-13 | 2002-12-12 | FLJ1115 AS MODIFIER OF THE Apaf-1 PATHWAY AND METHODS OF USE |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002360586A8 AU2002360586A8 (en) | 2003-06-30 |
AU2002360586A1 true AU2002360586A1 (en) | 2003-06-30 |
Family
ID=26992055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002360586A Abandoned AU2002360586A1 (en) | 2001-12-13 | 2002-12-12 | FLJ1115 AS MODIFIER OF THE Apaf-1 PATHWAY AND METHODS OF USE |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002360586A1 (en) |
WO (1) | WO2003052069A2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6228603B1 (en) * | 1997-05-22 | 2001-05-08 | The Burnham Institute | Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity |
AU739350B2 (en) * | 1997-06-05 | 2001-10-11 | University Of Texas System, The | APAF-1, the CED-4 human homolog, an activator of caspase-3 |
US6403765B1 (en) * | 1998-06-16 | 2002-06-11 | Thomas Jefferson University | Truncated Apaf-1 and methods of use thereof |
-
2002
- 2002-12-12 AU AU2002360586A patent/AU2002360586A1/en not_active Abandoned
- 2002-12-12 WO PCT/US2002/039867 patent/WO2003052069A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003052069A2 (en) | 2003-06-26 |
AU2002360586A8 (en) | 2003-06-30 |
WO2003052069A3 (en) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002310256A1 (en) | Ppp2cs as modifiers of the p53 pathway and methods of use | |
AU2002357119A1 (en) | Mitocidal compositions and methods | |
AU2002315389A1 (en) | Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof | |
AU2002314474A1 (en) | Grating structures and methods of making the grating structures | |
EP1421384A4 (en) | Hprp4s as modifiers of the p53 pathway and methods of use | |
AU2002315388A1 (en) | Novel phenylamino-pyrimidines and uses thereof | |
EP1402262A4 (en) | MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE | |
AU2002239933A1 (en) | Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU2002337916A1 (en) | Modifier of the p53 pathway and methods of use | |
AUPR446801A0 (en) | Novel compositions and uses therefor | |
AU2002343100A1 (en) | The use of metal-chelating adsorbents | |
AU2002355432A1 (en) | Kavalactone compositions and methods of use | |
AU2002360974A1 (en) | Novel use of alloys | |
AU2002360586A1 (en) | FLJ1115 AS MODIFIER OF THE Apaf-1 PATHWAY AND METHODS OF USE | |
AU2002359869A1 (en) | Pak5-related compositions and methods | |
AU2002337915A1 (en) | Ctsls as modifiers of the p53 and apaf-1 pathways and methods of use | |
AU2002332130A1 (en) | Msrebps as modifiers of the srebp pathway and methods of use | |
AU2002357817A1 (en) | Klcs as modifiers of the p53 pathway and methods of use | |
AU2002312283A1 (en) | Srpks as modifiers of the p53 pathway and methods of use | |
AU2002345486A1 (en) | Slc13as as modifiers of the p53 pathway and methods of use | |
AU2002303951A1 (en) | Glras as modifiers of the p53 pathway and methods of use | |
AU2002303947A1 (en) | Pecis as modifiers of the p53 pathway and methods of use | |
AU2002307237A1 (en) | Carboxybenzopyran derivatives and compositions | |
AU2002314874A1 (en) | Modifiers of the p53 pathway and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |